Custom Search


Friday 01 February 2002

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

By: Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry.

J Am Acad Child Adolesc Psychiatry 2002 Feb;41(2 Suppl):26S-49S

This practice parameter describes treatment with stimulant medication. It uses an evidence-based medicine approach derived from a detailed literature review and expert consultation. Stimulant medications in clinical use include methylphenidate, dextroamphetamine, mixed-salts amphetamine, and pemoline. It carries FDA indications for treatment of attention-deficit/hyperactivity disorder and narcolepsy.

Use of this site is subject to the following terms of use